Daily Stock Analysis, BIOS, BioScrip Inc, priceseries

BioScrip Inc. Daily Stock Analysis
Stock Information
Open
2.62
Close
2.68
High
2.72
Low
2.60
Previous Close
2.62
Daily Price Gain
0.06
YTD High
2.72
YTD High Date
Jun 23, 2017
YTD Low
1.07
YTD Low Date
Jan 3, 2017
YTD Price Change
1.29
YTD Gain
92.81%
52 Week High
3.43
52 Week High Date
Oct 5, 2016
52 Week Low
0.98
52 Week Low Date
Dec 29, 2016
52 Week Price Change
0.19
52 Week Gain
7.63%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Apr 2. 2015
4.46
Apr 27. 2015
5.19
16 Trading Days
16.28%
Link
LONG
Aug 24. 2015
1.95
Sep 23. 2015
2.72
21 Trading Days
39.26%
Link
LONG
Oct 28. 2015
2.06
Oct 29. 2015
2.18
1 Trading Days
5.83%
Link
LONG
Nov 2. 2015
2.09
Nov 12. 2015
2.54
8 Trading Days
21.74%
Link
LONG
Feb 16. 2016
1.69
Mar 10. 2016
2.19
17 Trading Days
29.66%
Link
LONG
Apr 8. 2016
2.18
May 2. 2016
2.54
16 Trading Days
16.71%
Link
LONG
Sep 30. 2016
2.89
Oct 11. 2016
3.05
7 Trading Days
5.58%
Link
LONG
Jan 3. 2017
1.39
Jan 5. 2017
1.48
2 Trading Days
6.83%
Link
Company Information
Stock Symbol
BIOS
Exchange
NasdaqGS
Company URL
http://www.bioscrip.com
Company Phone
720 697 5200
CEO
Daniel E. Greenleaf
Headquarters
Colorado
Business Address
1600 BROADWAY, SUITE 950, DENVER, CO 80202
Sector
Equity
Industry Category
Health Services
Industry Group
Home Health Care
CIK
0001014739
About

BioScrip, Inc. engages in the provision of home infusion and home care management solutions. It partners with physicians, hospital systems, skilled nursing facilities, healthcare payors, and pharmaceutical manufacturers to provide patients access to post-acute care services. The firm offers post-acute solutions, infusion services, and respiratory care services and home medical equipment. The company was founded in 1996 and is headquartered in Denver, CO.

Description

BioScrip, Inc. provides home infusion services in the United States. The company engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. It is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. BioScrip, Inc. offers its services at patient's homes, outpatient clinics, nursing facilities, physician's offices, and ambulatory infusion centers. The company markets and sells its products and services through sales and marketing representatives, payor relationships, and other government programs. BioScrip, Inc. was founded in 1993 and is based in Denver, Colorado.